INTERSECT ENT INC - COM (XENT)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
6,143,740
Share change
+35,877
Total reported value
$113,966,394
Price per share
$18.55
Number of holders
53
Value change
+$1,899,645
Number of buys
32
Number of sells
20

Institutional Holders of INTERSECT ENT INC - COM (XENT) as of Q4 2014

As of 31 Dec 2014, INTERSECT ENT INC - COM (XENT) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,143,740 shares. The largest 10 holders included Norwest Venture Partners XI, LP, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, LORD, ABBETT & CO. LLC, Novo A/S, ROYCE & ASSOCIATES LLC, MILLENNIUM MANAGEMENT LLC, FEDERATED INVESTORS INC /PA/, WALL STREET ASSOCIATES, and MORGAN STANLEY. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.